Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The antithrombotic pathway (local effect) encompasses molecular and cellular mechanisms that prevent or reduce blood clot formation specifically at sites of vascular injury. Strategies focus on inhibiting platelet activation, modulating the coagulation cascade, or combining both approaches locally to minimize systemic side effects and bleeding risks. Key targets include platelet receptors like P2Y12 and integrin αIIbβ3, as well as coagulation factors like Factor Xa and Thrombin.
Multiple mechanisms, including inhibition of platelet aggregation (via P2Y12 receptor or integrin αIIbβ3 antagonism) and coagulation cascade modulation (e.g., Factor Xa or Thrombin inhibition)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antithrombotic Pathway (Local Effect).